Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes

[1]  R. Greil,et al.  Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance. , 2017, Anticancer research.

[2]  D. Caridha,et al.  Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei , 2016, Malaria Journal.

[3]  B. Pybus,et al.  Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art. , 2016, Pharmacology & therapeutics.

[4]  B. Tekwani,et al.  Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes , 2016, Malaria Journal.

[5]  J. Rubio,et al.  Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial , 2016, Malaria Journal.

[6]  B. Tekwani,et al.  Enantioselective Pharmacokinetics of Primaquine in Healthy Human Volunteers , 2015, Drug Metabolism and Disposition.

[7]  B. Tekwani,et al.  Differential CYP 2D6 Metabolism Alters Primaquine Pharmacokinetics , 2015, Antimicrobial Agents and Chemotherapy.

[8]  B. Tekwani,et al.  Enantioselective metabolism of primaquine by human CYP2D6 , 2014, Malaria Journal.

[9]  R. Noviyanti,et al.  The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea , 2014, Malaria Journal.

[10]  L. Walker,et al.  An LC–MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model , 2014, European Journal of Drug Metabolism and Pharmacokinetics.

[11]  Antonio Ayala,et al.  Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.

[12]  A. Verhoeven,et al.  Inborn defects in the antioxidant systems of human red blood cells. , 2014, Free radical biology & medicine.

[13]  J. G. Mohanty,et al.  Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging , 2013, Front. Physiol..

[14]  W. Mccarthy,et al.  Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. , 2013, The New England journal of medicine.

[15]  D. Caridha,et al.  The metabolism of primaquine to its active metabolite is dependent on CYP 2D6 , 2013, Malaria Journal.

[16]  L. Walker,et al.  Synthesis of [13C6]primaquine. , 2013, Journal of labelled compounds & radiopharmaceuticals.

[17]  N. White.  Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.

[18]  B. Tekwani,et al.  Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling. , 2013, Journal of mass spectrometry : JMS.

[19]  S. Percário,et al.  Oxidative Stress in Malaria , 2012, International journal of molecular sciences.

[20]  C. Rodrigo,et al.  Primaquine in vivax malaria: an update and review on management issues , 2011, Malaria Journal.

[21]  A. Pantaleo,et al.  Pharmacological properties of indolone-N-oxides controlled by a bioreductive transformation in red blood cells? , 2011 .

[22]  R. Moreira,et al.  Primaquine revisited six decades after its discovery. , 2009, European journal of medicinal chemistry.

[23]  M. Cappellini,et al.  Glucose-6-phosphate dehydrogenase deficiency , 2008, The Lancet.

[24]  B. Tekwani,et al.  8-Aminoquinolines: future role as antiprotozoal drugs , 2006, Current opinion in infectious diseases.

[25]  A. Magill,et al.  Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. , 2006, The American journal of tropical medicine and hygiene.

[26]  O. Wiest,et al.  Mechanistic pathways of the hydroxyl radical reactions of quinoline. 2. Computational analysis of hydroxyl radical attack at C atoms. , 2005, The journal of physical chemistry. A.

[27]  O. Wiest,et al.  Mechanistic pathways of the hydroxyl radical reactions of quinoline. 1. Identification, distribution, and yields of hydroxylated products. , 2005, The journal of physical chemistry. A.

[28]  Frédéric Taran,et al.  The reaction of coumarin with the OH radical revisited: hydroxylation product analysis determined by fluorescence and chromatography , 2005 .

[29]  D. McMillan,et al.  Primaquine-Induced Hemolytic Anemia: Susceptibility of Normal versus Glutathione-Depleted Rat Erythrocytes to 5-Hydroxyprimaquine , 2004, Journal of Pharmacology and Experimental Therapeutics.

[30]  K. Becker,et al.  Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. , 2004, International journal for parasitology.

[31]  K. Liu,et al.  On the application of 4-hydroxybenzoic acid as a trapping agent to study hydroxyl radical generation during cerebral ischemia and reperfusion , 2002, Molecular and Cellular Biochemistry.

[32]  A. Favier,et al.  Determination of salicylate hydroxylation products as an in vivo oxidative stress marker. , 2000, Free radical biology & medicine.

[33]  M. Highley,et al.  Role of red blood cells in pharmacokinetics of chemotherapeutic agents. , 1999, Anti-cancer drugs.

[34]  B. Halliwell,et al.  Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. , 1996, Annals of the rheumatic diseases.

[35]  B. Halliwell,et al.  Aromatic hydroxylation of phenylalanine as an assay for hydroxyl radicals. Measurement of hydroxyl radical formation from ozone and in blood from premature babies using improved HPLC methodology. , 1994, Analytical biochemistry.

[36]  O. Augusto,et al.  Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo. , 1994, Biochemical pharmacology.

[37]  R. Bolli,et al.  Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. , 1993, Circulation research.

[38]  N. White,et al.  Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. , 1993, British journal of clinical pharmacology.

[39]  R. Gupta,et al.  Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin. , 1988, Biochemical pharmacology.

[40]  P. Cossum,et al.  Role of the red blood cell in drug metabolism , 1988, Biopharmaceutics & drug disposition.

[41]  J. Eaton,et al.  Oxidants, oxidant drugs, and malaria. , 1988, Journal of medicinal chemistry.

[42]  Fletcher Ka,et al.  Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. , 1988 .

[43]  C. Canfield,et al.  Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates. , 1985, Toxicology and applied pharmacology.

[44]  S. Sarangan,et al.  Rapid Aromatic Hydrogen Exchange in the Antimalarial Primaquine , 1984, Pharmaceutical Research.

[45]  A. Breckenridge,et al.  Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. , 1984, British journal of clinical pharmacology.

[46]  H. Notopuro,et al.  Glucose-6-phosphate dehydrogenase deficiency. , 1972, Paediatrica Indonesiana.

[47]  J. George,et al.  Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage. , 1966, The Journal of clinical investigation.

[48]  P. Hochstein,et al.  GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS. , 1964, Biochemistry.

[49]  A. Tarlov,et al.  Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. , 1962, Archives of internal medicine.

[50]  C. Clayman,et al.  4. TOXICITY OF PRIMAQUINE IN NEGROES , 1952 .

[51]  D. Taylor,et al.  A metabolite of pamaquine from chickens. , 1951, The Journal of pharmacology and experimental therapeutics.

[52]  D. Taylor,et al.  A Metabolic Intermediate of Pamaquine from Chickens , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[53]  O. Wiest,et al.  Radical-induced oxidative transformation of quinoline , 2003 .

[54]  C. Clayman,et al.  Toxicity of primaquine in Negroes. , 1952, Journal of the American Medical Association.

[55]  F. Schönhöfer.  Über die Bedeutung der chinoiden Bindung in Chinolinverbindungen für die Malariawirkung , 1942 .